Belite Bio (BLTE) Shares Outstanding (2020 - 2025)

Belite Bio has reported Shares Outstanding for 6 years, with the latest figure at $39.4 billion in Q4 2025.

• For the quarter ending Q4 2025, Shares Outstanding rose 123428.19% year-over-year to $39.4 billion; the trailing twelve-month figure through Dec 2025 stood at $39.4 billion (up 123428.19% YoY), and the FY2025 full-year result was $39.4 million, up 23.53% from the prior year.
• Shares Outstanding for Q4 2025 stood at $39.4 billion, up from $31.9 million in the prior quarter.
• The five-year high for Shares Outstanding was $39.3 billion in Q4 2025, with the low at $10.3 million in Q4 2021.
• Average Shares Outstanding over 5 years is $7.9 billion, with a median of $29.1 million recorded in 2023.
• Year-over-year, Shares Outstanding rose 7.38% in 2021 and soared 123428.19% in 2025.
• Tracing BLTE's Shares Outstanding over 5 years: stood at $10.3 million in 2021, then jumped by 142.34% to $24.9 million in 2022, then climbed by 17.07% to $29.1 million in 2023, then rose by 9.29% to $31.9 million in 2024, then soared by 123428.19% to $39.4 billion in 2025.
• The last three Shares Outstanding figures came in at $39.4 billion (Q4 2025), $31.9 million (Q4 2024), and $29.1 million (Q4 2023), per Business Quant data.

Peer Comparison